BioStem Technologies, Inc. (BSEM) Misses Q1 EPS by 41c, provides guidance

BioStem Technologies, Inc. (OTC: BSEM) reported Q1 EPS of ($0.39), $0.41 worse than the analyst estimate of $0.02. Revenue for the quarter came in at $10.1 million versus the consensus estimate of $55.2 million.

GUIDANCE:

BioStem Technologies, Inc. sees Q1 2026 revenue of $5-6 million.

For earnings history and earnings-related data on BioStem Technologies, Inc. (BSEM) click here.

You May Also Be Interested In

• FDA Committee Recommends To Widen Access To Bpc-157 Peptide
• Ladder Capital (LADR) Misses Q2 EPS by 12c
• Old Second Bancorp (OSBC) Misses Q2 EPS by 1c